Jbf Capital, Inc. Biomarin Pharmaceutical Inc Transaction History

Jbf Capital, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 12, 2019	SELL	$80.14 - $106.07 $846,278 - $1.12 Million	-10,560 Closed	0 $0
Q2 2018 Aug 09, 2018	SELL	$76.01 - $99.03 $152,020 - $198,060	-2,000 Reduced 15.92%	10,560 $995,000
Q1 2018 May 11, 2018	BUY	$77.67 - $92.63 $975,535 - $1.16 Million	12,560 New	12,560 $1.02 Million

623

181M

1.73M

1.73M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $15.3B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Jbf Capital, Inc., based on Form 13F filings with the SEC.

Stay updated on Jbf Capital, Inc. with notifications on news.